Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on May 20, 2025
Fasoo Explores AI Security and Governance at iSMG Data Security Summit in Dallas
EIN Presswire
·
May 20, 2025
SEOUL, SOUTH KOREA, May 20, 2025 /EINPresswire.com/ -- Fasoo, a leader in data-centric security, successfully concluded its participation at the ISMG Data Security Summit in Dallas, where Ron Arden, Executive Vice President, CTO, and COO, led an …
中国患者越来越多的JY整形外科皮肤科扩大韩中美容医疗交流
EIN Presswire
·
May 20, 2025
对Ulthera·钛提拉术、皮肤助推器等高功能施术的需求增加 继中国医疗团队访问之后, 正式开始交流, 确认K-美容的地位 SEOUL, GANGNAM, SOUTH KOREA, May 20, 2025 /EINPresswire.com/ -- 位于首尔清潭洞的JY整形外科皮肤科继中国医疗团队的正式访问之后, 当地患者也接连访问, 作为韩中美容医疗交流的中心备受关注。 据JY整形外科皮肤科透露, 最近中国患者的访问次数不断增加, 特别是对Ulthera …
Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal
GlobeNewswire
·
May 20, 2025
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Enlivex Selected to Present at Israeli BioMed 2025 Conference
GlobeNewswire
·
May 20, 2025
Presentation to highlight Allocetra™ and the therapeutic potential of macrophage reprogramming in inflammatory diseases Ness-Ziona, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage …
SELLAS Life Sciences to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase
GlobeNewswire
·
May 20, 2025
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Aventis Energy Provides Recent Exploration Insights at the Corvo Uranium Project
GlobeNewswire
·
May 20, 2025
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Aventis Energy. (“Aventis” or the “Company”) (CSE: AVE | OTC: VBAMF), is pleased to provide a comprehensive summary of exploration insights and historical data gathered at its Corvo Uranium …
ALX Oncology Highlights Differentiated Design, Preclinical Data and Development Plans for EGFR-Targeted ADC, ALX2004, in R&D Webcast Event
GlobeNewswire
·
May 20, 2025
- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed with every component optimized to maximize the therapeutic window by reducing toxicity - Following recent …
Praxis Precision Medicines to Participate in Upcoming Conferences
GlobeNewswire
·
May 20, 2025
BOSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
PRECISION CLEANING MANUFACTURER JE CLEANTECH DELIVERS HEALTHY PERFORMANCE IN 2024
GlobeNewswire
·
May 20, 2025
Increase in sales by S$1 million for precision cleaning systems and S$0.3 million for the provision of centralized dishwashing and ancillary services in Singapore Overall gross profit margin yield higher compared to the corresponding year SINGAPORE, May 20 …
Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis
GlobeNewswire
·
May 20, 2025
NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch biotechnology company developing antibody-based therapies to treat severe immune disorders, today announced that it has enrolled the first patient in a Phase 1/2 clinical …
Philikos kondigt de start aan van een klinische fase 1/2-studie met T-Guard® bij patiënten met systemische sclerose
GlobeNewswire
·
May 20, 2025
NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., een Nederlands biotechnologiebedrijf dat op antilichamen gebaseerde therapieën ontwikkelt voor de behandeling van ernstige immuunziekten, heeft vandaag aangekondigd dat de eerste …
MicroAlgo Inc. Researches Quantum Machine Learning Algorithms to Accelerate Machine Learning Tasks
GlobeNewswire
·
May 20, 2025
shenzhen, May 20, 2025 (GLOBE NEWSWIRE) -- Shenzhen, May. 20, 2025/––MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), announced that quantum algorithms will be deeply integrated with machine learning to explore practical application scenarios …
PDD Holdings to Report First Quarter 2025 Unaudited Financial Results on May 27, 2025
GlobeNewswire
·
May 20, 2025
DUBLIN and SHANGHAI, May 20, 2025 (GLOBE NEWSWIRE) -- PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD) today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before U.S. markets open …
Revival Gold Commences 2025 Field Work and Provides Operational Update
GlobeNewswire
·
May 20, 2025
TORONTO, May 20, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to announce the start of this year’s field work and provide an update on operational activities at the Company’s gold …
Graphite Electrode Joint Market Trends, Growth and Industry Drivers | Exactitude Consultancy
GlobeNewswire
·
May 20, 2025
Luton, Bedfordshire, United Kingdom, May 20, 2025 (GLOBE NEWSWIRE) -- The graphite electrode joint is a critical component in electric arc furnace (EAF) steelmaking and other high-temperature industrial processes. It connects segments of graphite …
Acoramidis Reduced Incidence of Atrial Fibrillation Events in Patients with ATTR-CM
GlobeNewswire
·
May 20, 2025
- In a post-hoc analysis of ATTRibute-CM, acoramidis reduced the annual frequency of CVH due to AF/AFL by 43% compared to placebo and reduced the incidence of new-onset AF/AFL by 17% in the subgroup with no prior history of AF compared to placebo - In the …
Micro-Volume Spectrophotometer Market reach over $1.4 billion by 2034 | Exactitude Consultancy
GlobeNewswire
·
May 20, 2025
Luton, Bedfordshire, United Kingdom, May 20, 2025 (GLOBE NEWSWIRE) -- The micro-volume spectrophotometer is a specialized analytical instrument designed to measure the concentration and purity of biological samples using only microliters of volume. By …
Midland commence un programme d’exploration aurifère sur son projet Caniapisc Au à la Baie James
GlobeNewswire
·
May 20, 2025
MONTRÉAL, 20 mai 2025 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland ») (TSX-V : MD) a le plaisir d’annoncer le début d’un programme d’exploration pour l’or sur son projet Caniapisc Au, ainsi que présenter les résultats des tills de 2024, dans les …
Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome
GlobeNewswire
·
May 20, 2025
Company continues to advance QRX003 in late-stage clinical trials in Netherton Syndrome patients Regulatory milestone provides 10 years of market exclusivity in Europe upon approval ASHBURN, Va., May 20, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. …
Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution
GlobeNewswire
·
May 20, 2025
NEW YORK and MELBOURNE, Australia, May 20, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company pioneering the development of combination drug therapies, today announced …